These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 855389)

  • 1. [Pharmacokinetics in liver cirrhosis].
    Ackermann E
    Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver disease and drug therapy.
    Black M
    Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].
    Heni N; Lehnhardt G; Glogner P
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):253-61. PubMed ID: 965132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
    Chauhan CK; Nanivadekar SA; Billimoria FR
    Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic clearance of drugs in kidney failure].
    Balant L
    Nephrologie; 1983; 4(2):45-7. PubMed ID: 6136004
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Handling of drugs by cirrhotic patients].
    Danan G; Pariente A
    Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Side effects of drugs--predictable hazards for patients with liver disease].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
    Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
    Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver metabolism of drugs (author's transl)].
    Darnis F
    MMW Munch Med Wochenschr; 1976 Jun; 118(25):805-10. PubMed ID: 59311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics and drug metabolism in children].
    Prandota J; Pankow-Prandota L
    Pediatr Pol; 1979 Jul; 54(7):781-8. PubMed ID: 394112
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prescription of drugs in liver diseases].
    Held H
    Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug disposition in liver disease.
    Shand DG
    N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent pharmacokinetics: emphasis on phase I metabolism.
    Dayton PG; Sanders JE
    Drug Metab Rev; 1983; 14(3):347-405. PubMed ID: 6347591
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications of chronic liver disease.
    Chung RT; Jaffe DL; Friedman LS
    Crit Care Clin; 1995 Apr; 11(2):431-63. PubMed ID: 7788540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.